Related Experiment Video
Updated: Aug 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[PREVENCAT study: control of cardiovascular risk in primary care]
Luis A Alvarez-Sala1, Carmen Suárez, Teresa Mantilla
1Departamento de Medicina, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Insights
Cardiovascular risk factor control is insufficient in primary care patients with hypertension, diabetes, and hypercholesterolemia. Metabolic syndrome affects half of these patients, highlighting a critical public health concern.
Area of Science:
- Cardiology
- Primary Care Medicine
- Public Health
Background:
- Cardiovascular risk factors (CVRF) are often studied individually.
- The PREVENCAT study addresses CVRF control in patients with hypertension (HT), type 2 diabetes mellitus (DM2), and/or hypercholesterolemia (HC) in primary care.
Purpose of the Study:
- To estimate the control of CVRF in primary care patients with HT, DM2, and/or HC.
- To assess the prevalence of Metabolic Syndrome (MS) in this patient group.
Main Methods:
- A multicenter, cross-sectional study involving primary care physicians in Spain.
- Recruitment of patients diagnosed with HT, DM2, and/or HC.
- Assessment of blood pressure, cholesterol, glycaemia, obesity, smoking status, and physical activity.
Main Results:
- 2,649 patients were recruited; 51.6% were women, with a mean age of 64 years.
- Hypertension was the most frequent diagnosis (78.9%), followed by hypercholesterolemia (58.4%) and DM2 (37.4%).
- Control rates were suboptimal: 40.0% for blood pressure, 42.6% for cholesterol, and 62.7% for basal glycaemia. Only 15.6% had a healthy BMI, 46.2% practiced regular physical activity, and 87.5% were non-smokers. The prevalence of metabolic syndrome was 50.6%.
Conclusions:
- Cardiovascular risk factor control in primary care is inadequate.
- Less than half of patients with HT, DM2, and HC are effectively managed.
- Overweight and sedentary lifestyles present significant challenges in this population.
Background And Objective:
Most studies of cardiovascular risk factors (CVRF) conducted in our environment concentrate in a single CVRF. The PREVENCAT study was designed to estimate the control of CVRF in the population attended in primary care presenting arterial hypertension (HT), type 2 diabetes mellitus (DM2) and/or hypercholesterolemia (HC) as well as to assess the prevalence of Metabolic Syndrome in these patients.
Patients And Method:
Multicenter, cross-sectional study, in patients with HT, DM2 and/or HC, consecutively recruited by primary care physicians in Spain. The blood pressure, cholesterol, basal glycaemia, obesity, smoking and physical activity were assessed. The degree of control of these CVRF and the prevalence of MS were estimated.
Results:
2,649 patients were recruited, aged 64 (11.3) years, with a 51.6% of women. The most frequent diagnosis was HT (78.9%), followed by HC (58.4%) and DM2 (37.4%). In the whole sample, the percentages of patients who had a control or had initially normal values of blood pressure, cholesterol and basal glycemia were 40.0% (confidence interval [CI], 95% 38.2-41.9), 42.6% (95% CI, 40.5-44.7) and 62.7% (95% CI, 60.8-64.5), respectively. 15.6% of cases (95% CI, 14.3-17.0) had body mass index < or = 25 kg/m2; 87.5% were non-current smokers (95% CI, 86.2-88.8); and 46.2% practiced regular physical activity (95% CI, 44.3-48.1). 40% of patients had < or = 2 CVRF in good control. The prevalence of metabolic syndrome was 50.6% (95% CI, 48.7-52.5).
Conclusions:
The control of the CVRF considered in primary care attended population is insufficient. Hardly one of each 2 patients with HT, DM2 and HC is under control. The overweight and sedentarism control is still poorer.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Preventive Healthcare Services
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease III: Medical Management